Molecular modeling of human cytochrome P450–substrate interactions

The results of homology modeling of 10 human cytochrome P450 (CYP) enzymes involved in the Phase 1 metabolism of drugs and other foreign compounds are reported. The models have been constructed from the CYP102 hemoprotein domain template for which the substrate-bound crystallographic coordinates are available. Selective substrates of individual human P450s: CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, and CYP4A11 are all shown to fit within the corresponding enzymes' active sites in such a manner that is consistent with reported experimental data for both known pathways of substrate metabolism and from the results of site-directed mutagenesis, either in those particular human P450 enzymes concerned or for ones within the same subfamily. The self-consistency of these homology models indicates that they may have potential utility for the pre-screening of novel drug structures.

[1]  M H Tarbit,et al.  Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. , 1999, Toxicology.

[2]  J. M. Pratt,et al.  The P450 catalytic cycle and oxygenation mechanism. , 1998, Drug metabolism reviews.

[3]  D. Lewis,et al.  Cytochrome P450 Substrate Specificities, Substrate Structural Templates and Enzyme Active Site Geometries , 1999, Drug metabolism and drug interactions.

[4]  M H Tarbit,et al.  Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  C. Ioannides.  Cytochromes P450 Metabolic and Toxicological Aspects , 1996 .

[6]  D. Lewis,et al.  The CYP2 family: models, mutants and interactions. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  T. Walle,et al.  Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  D. Lewis,et al.  Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. , 1999, Toxicology.

[9]  D. Lewis.  Modelling Human Cytochromes P450 for Evaluating Drug Metabolism: An Update , 2000, Drug metabolism and drug interactions.

[10]  Benveniste,et al.  Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.

[11]  Slobodan Petar Rendic,et al.  Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.

[12]  D. Lewis.  Guide to Cytochromes P450 : structure and function , 2001 .

[13]  M H Tarbit,et al.  Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  M H Tarbit,et al.  Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: structural studies on specific CYP2D6 substrate metabolism. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  D. Lewis,et al.  Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects. , 2000, Biochimica et biophysica acta.

[16]  M H Tarbit,et al.  Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  D. Lewis,et al.  Cytochromes P450: structure, function and mechanism. , 1996 .

[18]  M H Tarbit,et al.  Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate. , 1998, Chemico-biological interactions.

[19]  D. Lewis,et al.  On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism. , 2000, Biochemical pharmacology.

[20]  D. Lewis,et al.  Molecular modelling of CYP4A subfamily members based on sequence homology with CYP102. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  M H Tarbit,et al.  Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  D. Lewis.  Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity. , 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[23]  D. Lewis,et al.  Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles. , 2000, Toxicology.